NetworkNewsBreaks Archive - Page 951 of 2081

WednesdayAug 18, 2021 10:26 am

NetworkNewsBreaks – ISW Holdings Inc. (ISWH) Announces Strategic Agreement for Material Broadening of In-House Mining Capacity

ISW Holdings (OTC: ISWH) (transitioning to “BlockQuarry,” pending name change), a Nevada-based portfolio company with primary commercial-stage operations in cryptocurrency mining, today announced the completion of an asset purchase agreement with Minerset LLC, a Delaware limited liability company. The agreement provides for the purchase by ISW Holdings of 400 state-of-the-art cryptocurrency miners. “As we have discussed in our recent communications, we are actively engaged in expansion in both our hosting and mining segments,” said Alonzo Pierce, president and chairman of ISW Holdings. “This asset purchase agreement with Minerset represents a material broadening of our in-house mining capacity and will enable…

WednesdayAug 18, 2021 10:08 am

NetworkNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Receives Initial PO from Alberta Gaming and Liquor Commission

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), an emerging leader in innovative health and wellness beverages and products, has received multiple product listings and purchase orders from Alberta Gaming and Liquor Commission (“AGLC”). The initial order includes international bestsellers Keef and Green Monké products as well BevCanna’s new brand, State B Beverages. The products are slated to be on the shelves of more than 600 licensed private retailers by the fall; the products will also be available online. AGLC is the government of Alberta's agency that oversees the gaming, liquor and cannabis industries in Alberta; the agency also operates the…

WednesdayAug 18, 2021 9:48 am

NetworkNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Releases Detailed Summary of National Study

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering from sleep-disordered breathing, including mild-to-moderate obstructive sleep apnea (“OSA”), has released a detailed summary of the results from its most recent national study. Those results include the fact that one in four patients in the study who used Vivos’ FDA Class 1 DNA appliance for certain orofacial anomalies reported no remaining OSA symptoms; that is officially defined as patients in post treatment having an Apnea Hypopnea Index (“AHI”) score of less than 5. According to the announcement, before the…

WednesdayAug 18, 2021 9:27 am

NetworkNewsBreaks – TAAT Global Alternatives Inc. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) Expands into Seven States in Only Two Months

TAAT(TM) Global Alternatives (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) announced that, in only two months, its flagship product TAAT(TM) has been picked up for distribution in seven new U.S. states; the most recent states carrying the product are Alabama, California, Florida, Michigan and Mississippi. A few weeks ago, the company signed a distribution agreement that included Georgia; Illinois is also now carrying TAAT products. These states join Ohio, where the product was originally launched. TAAT tobacco-free and nicotine-free alternative to traditional cigarettes is also available online through the company’s e-commerce operations. In addition, the company has announced plans for its…

TuesdayAug 17, 2021 2:53 pm

NetworkNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Standing Distinct in Psychedelic-Derived Treatments Space

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) is focused on driving significant innovation with its drug development pipeline. Tryp is leveraging its Psilocybin-for-Neuropsychiatric Disorders (“PFN”) program in the development of treatments for chronic pain indications including fibromyalgia, phantom limb pain and complex regional pain syndrome. In addition, the company is preparing to initiate a phase 2a clinical trial for eating disorders including binge eating and hypothalamic obesity. “With the growing popularity and proliferation of psychedelics, many companies are pursuing therapeutic indications with the compounds,” reads a recent article discussing Tryp’s positioning. “However, very few have initiated phase 2a studies. Tryp Therapeutics…

TuesdayAug 17, 2021 2:40 pm

NetworkNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Collaborates to Mark Important Milestone to Restore Critical RE Supply Chains

Energy Fuels (NYSE American: UUUU) (TSX: EFR) and Neo Performance Materials (TSX: NEO) recently announced that the first container of mixed rare earth (“RE”) carbonate was shipped from UUUU’s White Mesa Mill in Utah to NEO’s rare earth separation facility in Estonia. This shipment marked an important milestone toward restoring the critical U.S. and European rare earth supply chains. Chemours (NYSE: CC), based in Georgia, mines natural monazite that contains both the rare earth elements and naturally occurring uranium. “The rare earth elements are then processed into RE carbonate by UUUU’s White Mesa Mill before being shipped off to Estonia…

TuesdayAug 17, 2021 2:29 pm

NetworkNewsBreaks – FinovateFall Conference Provides Face-to-Face Gathering, Networking Opportunity

FinovateFall Conference has announced its fall event, a return to in-person gatherings. The conference is slated for Sept. 13–15, 2021, and will be held in the New York Marriott Marquis Times Square Hotel. Although the conference will be an in-person event, digital-only access is available for participants wanting to attend the event virtually. The agenda for this elite event features more than 90 expert speakers who will address relevant and timely fintech topics, including “The Synergistic Intersection of Community Banks, Fintechs and SMEs”; “How Financial Services Companies Can Play a Key Role Helping Clients on their ESG & Climate Change…

TuesdayAug 17, 2021 2:24 pm

NetworkNewsBreaks – RAPT Therapeutics Inc. (NASDAQ: RAPT) Secures $143.7M in Underwritten Public Offering

RAPT Therapeutics (NASDAQ: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases, has closed its previously announced underwritten public offering. According to the update, the offering consisted of 4,356,060 shares of RAPT’s common stock, each at a public offering price of $33.00, which includes 568,181 shares issued and sold upon full exercise of the underwriters’ option to purchase additional shares of common stock. RAPT offered all of the shares of common stock and secured approximately $143.7 million in aggregate gross proceeds. Roth…

TuesdayAug 17, 2021 2:13 pm

NetworkNewsBreaks – InnerScope Hearing Technologies Inc. (INND) CEO to Present at Aug. 18, 2021, Investor Conferences

InnerScope Hearing Technologies (OTC: INND), an emerging and disruptive leader in the direct-to-consumer (“DTC”) hearing technology space, today announced that its CEO Matthew Moore has been invited to present at two separate investor conferences on Wednesday, Aug. 18, 2021. According to the update, Moore will be hosting the live online presentations and answering questions from the investment community and existing shareholders. Moore’s presentations will highlight InnerScope’s positioning within the newly emerging market driven by upcoming deregulation of the hearing aid sector, which allows over-the-counter hearing aids to be sold in retail stores and pharmacies. Moore’s Aug. 18 presentations will begin…

TuesdayAug 17, 2021 1:45 pm

NetworkNewsBreaks – NexTech AR Solutions Corp. (OTCQB: NEXCF) (NEO: NTAR) (CSE: NTAR) (FSE: N29) Releases Next-Gen Ad Functionality

NexTech AR Solutions (OTCQB: NEXCF) (NEO: NTAR) (CSE: NTAR) (FSE: N29), an emerging leader in augmented reality (“AR”) for eCommerce, AR learning applications, AR-enhanced video conferencing and virtual events, has unveiled its next-generation ad technology. NexTech Ads offers rich and robust analytics that provide customers with data-driven insights that enable them to capture impressions, clicks, interactions and gain overall AR engagement data. In addition, NexTech customers can deliver compelling, effective 3D ads designed for Google that do not require application download. According to the announcement, the company reported click-through rates (“CTR”) of approximately 5% for 3D ads created with NexTech…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks